|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
FY2020
12 months to Dec 26, 2020
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash restructuring charges and other related costs | |||||
| Amortization of debt discount and issuance costs | |||||
| Operating lease expense | |||||
| Stock-based compensation expense | |||||
| Gain on extinguishment of debt | |||||
| Other, net | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from issuance of 2028 Notes | |||||
| 3.75% Convertible Senior Notes Due 2028 | |||||
| Convertible Senior Notes, 2.5%, Due March 1, 2027 | |||||
| Total proceeds from issuance of 2028 Notes | |||||
| Proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs of $3,380 | |||||
| Repayment of 2024 Notes | |||||
| Payment of debt issuance cost | |||||
| Proceeds from asset-based revolving credit facility | |||||
| Repayment of asset-based revolving credit facility | |||||
| Repayment of third-party manufacturing funding | |||||
| Repayment of mortgage payable | |||||
| Principal payments on finance lease obligations | |||||
| Payment of term license obligation | |||||
| Proceeds from issuance of common stock | |||||
| Tax withholding paid on behalf of employees for net share settlement | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest, net | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Transfer of inventory to fixed assets | |||||
| Property and equipment included in accounts payable and accrued liabilities | |||||
| Unpaid term licenses (included in accounts payable, accrued liabilities and other long term liabilities) | |||||
Loading...